Home
About
Overview
Sharing Data
ORCID
Help
History (38)
Placebo response rate in clinical trials of fistulizing Crohn's disease: systematic review and meta-analysis.
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY).
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort.
Treatment of breast carcinoma recurrent after adjuvant chemoimmunotherapy.
See All 38 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Treatment of breast carcinoma recurrent after adjuvant chemoimmunotherapy.
Treatment of breast carcinoma recurrent after adjuvant chemoimmunotherapy. J Surg Oncol. 1984 Aug; 26(4):233-7.
View in:
PubMed
subject areas
Adjuvants, Immunologic
Antineoplastic Combined Chemotherapy Protocols
BCG Vaccine
Breast Neoplasms
Clinical Trials as Topic
Cyclophosphamide
Doxorubicin
Female
Fluorouracil
Humans
Melphalan
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Staging
Prednisolone
Prospective Studies
Random Allocation
authors with profiles
Janardan Khandekar
Joseph Caprini